CARDIZEM SR
DILTIAZEM HYDROCHLORIDE
Approval overview CARDIZEM SR is listed in Drugs@FDA under application 019471 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient DILTIAZEM HYDROCHLORIDE Form and strength CAPSULE, EXTENDED RELEASE;ORAL - 60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor BIOVAIL Submission history Latest submission status date: 2003-03-21 00:00:00.
Structured Monograph
Clinical summary
Approval overview CARDIZEM SR is listed in Drugs@FDA under application 019471 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient DILTIAZEM HYDROCHLORIDE Form and strength CAPSULE, EXTENDED RELEASE;ORAL - 60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor BIOVAIL Submission history Latest submission status date: 2003-03-21 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.